Cargando…
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
Tumor angiogenesis has been identified to play a critical role in tumor growth and tumor progression, and is regulated by a balance of angiogenic and anti-angiogenic cytokines. Among them VEGF (vascular endothelial growth factor) and its signaling through its receptors are of crucial relevance. Inhi...
Autores principales: | Pircher, Andreas, Hilbe, Wolfgang, Heidegger, Isabel, Drevs, Joachim, Tichelli, André, Medinger, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211028/ https://www.ncbi.nlm.nih.gov/pubmed/22072937 http://dx.doi.org/10.3390/ijms12107077 |
Ejemplares similares
-
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
por: Pircher, Andreas, et al.
Publicado: (2017) -
Tumor angiogenesis and anti-angiogenic gene therapy for cancer
por: Li, Tinglu, et al.
Publicado: (2018) -
Clinical trials with anti-angiogenic agents in hematological malignancies
por: Medinger, Michael, et al.
Publicado: (2010) -
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012) -
Extracellular vesicles in tumor angiogenesis and resistance to anti‐angiogenic therapy
por: Ye, Zi‐Wu, et al.
Publicado: (2023)